#hydrogeltechnology

Burn ointments are specialized topical formulations designed to treat and accelerate the healing of first- and second-degree burns, minor cuts, abrasions, and sunburns. These products often combine antimicrobial agents, emollients, and pain-relieving ingredients to minimize infection risk, reduce inflammation, and promote tissue regeneration. Patients benefit from reduced scar formation, faster wound closure, and improved comfort during recovery. With an increase in industrial accidents, kitchen-related burns, and recreational injuries, the demand for effective burn-care solutions has surged.

  Get More Insights on Burn Ointment Market https://www.patreon.com/posts/burn-ointment-by-129681633  

The global hydrogel-based drug delivery system market size is anticipated to reach USD 11.77 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2024 to 2030. Hydrogels help in achieving spatial and temporal control over the release of the incorporated drug. Therefore, the surging demand for controlled releases drug delivery system across many therapeutic areas is a key factor expected to contribute to market growth during the forecast period.

Hydrogel-based drug delivery systems deliver the therapeutic drug directly at the target site and in a sustained manner. This can leverage beneficial outcomes such as improved efficacy, reduced side effects, and decreased dosage for patients and formulators. Hydrogel-based drug delivery systems are appealing and have been used in many branches of medicine such as oncology, pain management, immunology, cardiology, and wound management.

Hydrogel-based Drug Delivery System Market Report Highlights

Based on polymer origin, the synthetic segment held the largest proportion of market share in 2023

The hybrid segment is expected to witness the fastest growth rate over the forecast period owing to the development of stimuli-responsive hydrogel technology

The synthetic segment is anticipated to grow fast over the forecast period compared to natural hydrogels due to their high drug loading capacity and improved mechanical strength

Based on delivery route, the ocular segment accounted for the largest revenue share in 2023

The subcutaneous segment is expected to grow at a healthy rate over the forecast period owing to the increasing number of clinical and pre-clinical studies carried out

North America holds the largest revenue share in this market due to the presence of key companies in the region doing R&D on specific hydrogel-based drug delivery systems

In Asia Pacific, the market is expected to grow at the fastest rate over the forecast period due to large patient base, improving healthcare infrastructure, and surging demand for modern therapies

For More Details or Sample Copy please visit link @: Hydrogel-based Drug Delivery System Market Report

The unique physical properties of hydrogel attract their interest in use for drug delivery applications. The porosity and drug loading capacity of hydrogels can be adjusted by modifying the density of cross-linking. This helps them to protect liable large drug molecules from degradation increasing the half-life. Many research studies have been carried out to examining the delivery of insulin orally using hydrogel systems. As patient compliance issues are frequently reported with injectable insulins such innovation is expected to be a disruptive technology in the diabetes care market.

There are numerous clinical studies underway specific to hydrogel-based drug delivery systems and various hydrogel technologies have already received regulatory approval for biomedical application. However, the technological challenges including the absence of defined regulatory guidelines, chemistry, complex manufacturing and control paraments, and practical adaptability are major roadblocks in the successful implementation in drug delivery use. For instance, the fabrication of hydrogel is complex and varies significantly depending upon the hydrogel systems.

List of major companies in Hydrogel-based Drug Delivery System Market

GALDERMA

Blairex Laboratories, Inc

Johnson & Johnson

Bausch + Lomb.

Medtronic

Ocular Therapeutix, Inc.

Ferring B.V.

Endo, Inc.

Tolmar Inc

Hydrogel dressing is a type of wound dressing that is composed of a gel-like material primarily made up of water. It is designed to provide a moist environment for wound healing and can be used for a variety of wounds, including burns, ulcers, and surgical incisions. Hydrogel dressings have several beneficial properties for wound care. They are highly absorbent, which allows them to manage excess wound exudate (fluid) and create a moist environment necessary for wound healing.

The Hydrogel Dressing Market was valued at USD 181.98 Million in 2022 and is expected to register CAGR of 5.83% by 2032.

The rising incidence of chronic wounds, such as diabetic ulcers, pressure ulcers, and venous leg ulcers, is a significant factor driving the hydrogel dressing market.